The Effectiveness of Combined Use of Antioxidant and Glutamine in Abdominal Sepsis
https://doi.org/10.15360/1813-9779-2017-2-52-60
Abstract
Aim of the study: the effectiveness of concomitant use of antioxidant therapy with antioxidant 2-ethyl-6- methyl-3-hydroxypyridine succinate (mexidol) and intensive nutritional support with glutamine in patients with abdominal sepsis (AS). Materials and methods. 170 patients with abdominal sepsis (AS) involved in the study were separated into two groups. Patients of group 1 (control group, n=70) received basic treatment. Patients from group 2 (n=100) were divided into 2 subgroups. Patients from the subgroup 21 (n=70), in additon to the basic treatment, received intravenously, by drop infusion, mexidol (2000 mg per day) and dipeptiven (27.5 g per day), patients from subgroup 22 (n=30) additionally to that received per os glutamine. Survival analysis was carried out according to the Kaplan-Meier method with using of the Cox's F-test and Mantel-Cox test for testing of statistical hypotheses. Results. Treatment outcomes analysis showed that in the basic group 2, mortality was lower than in the control group 1. A statistically significant increase of cumulative part in the survivors was revealed using mexidol and glutamine. Conclusion. Concomitant intravenous administration of medications had positive effects on treatment outcomes. Following on from the analysis results, we may suggest that the pair mexidol + dipeptiven interrupts the cascade of development of abdominal sepsis and contributes to avoiding a critical condition during sepsis.
About the Authors
V. V. Nazaretyan
Voronezh city clinical hospital of emergency medical care № 1
Russian Federation
Russian Federation
V. N. Lukach
Omsk State Medical University, Ministry of Health of Russia
Russian Federation
Russian Federation
A. V. Kulikov
Voronezh city clinical hospital of emergency medical care № 1
Russian Federation
Russian Federation
References
1. Gusev E.Yu., Chereshnev V.A. Systemic inflammation: theoretical and methodological approaches to description of general pathological process model. Part I. General characteristic of the process. Patologicheskaya Fiziologiya i Eksperimentalnaya Terapiya. 2012; 4: 3–14. [In Russ.]
2. Gusev E.Yu., Chereshnev V.A. Evolution of inflammation. Tsitokiny i Vospalenie. 2012; 11 (4): 5–13. [In Russ.]
3. Kozlov V.K. Sepsis: etiology, immunopathogenesis, concept of modern immunotherapy. Kiev: Anna"T; 2007: 296. [In Russ.]
4. Povzun S.A. The most important syndromes: pathogenesis and patho" logical anatomy. Sankt"Peterburg: KOSTA; 2009: 480. [In Russ.]
5. Savelyev V.S., Gelfand B.R. (eds.). Sepsis: classification, clinical and diagnostic concept, and treatment. Practice guidelines. Moscow: Meditsinskoe Informatsionnoe Agentstvo; 2013: 360. [In Russ.]
6. Lagu T., Rothberg M.B., Shieh M.S., Pekow P.S., Steingrub J.S., Lindenauer P.K. Hospitalizations, costs, and outcomes of severe sepsis in the United States 2003 to 2007. Crit. Care Med. 2012; 40 (3): 754–761. http://dx.doi.org/10.1097/CCM.0b013e318232db65. PMID: 21963582
7. Levy M.M., Artigas A., Phillips G.S., Rhodes A., Beale R., Osborn T., Vincent J.L., Townsend S., Lemeshow S., Dellinger R.P. Outcomes of the Surviving Sepsis Campaign in intensive care units in the USA and Europe: a prospec" tive cohort study. Lancet Infect. Dis. 2012; 12 (12): 919–924. http://dx.doi.org/10.1016/S1473"3099(12)70239"6. PMID: 23103175
8. Vincent J.L., Abraham E. The last 100 years of sepsis. Am. J. Respir. Crit. Care Med. 2006; 173 (3): 256–263. http://dx.doi.org/10.1164/rccm. 200510"1604OE. PMID: 16239619
9. Wischmeyer P.E. The evolution of nutrition in critical care: how much, how soon? Crit. Care. 2013; 17 (Suppl 1): S7. http://dx. doi.org/10.1186/cc11505. PMID: 23514524
10. Bazhina E.S., Nikulin A.V., Khoroshilov S.E. Extracorporeal treatments for abdominal sepsis. Obshchaya Reanimatologiya = General Reanimatology. 2015; 11 (5): 45–66. http://dx.doi.org/10.15360/ 1813"9779"2015"5"45"66
11. Kudryavtsev A.N., Kulabukhov V.V., Chizhov A.G. The selection of hemofiltration regimen in sepsis. Obshchaya Reanimatologiya = General Reanimatology. 2016; 12 (2): 43–55. http://dx. doi.org/10.15360/1813"9779"2016"2"43"55. [In Russ., In Engl.]
12. Zilber A.P. Sketches of of respiratory medicine. Moscow: MEDPress" inform; 2007: 792. [In Russ.]
13. Gritsuk S.F., Bezrukov V.M. Syndrome of amino acid imbalance and metabolic dysfunction in critical conditions in surgery. Vestnik Intensivnoi Terapii. 2004; 2: 10–13. [In Russ.]
14. Gusev E.Yu., Zotova N.V., Lazareva M.A. Cytokine response and other differences between critical phases of sepsis"associated systemic inflammation. Meditsinskaya Immunologiya. 2014; 16 (2): 173–182. https://doi.org/10.15789/1563"0625"2014"2"173"182. [In Russ.]
15. Rebrova O.Yu. Statistical analysis of medical data: application software package STATISTICA. 3"rd ed. Moscow: MediaSfera; 2006: 305. [In Russ.]
16. Chereshnev V.A., Gusev E.Yu., Zotova N.V. Fundamental"applied aspects of systemic inflammation in terms of physiologic and typical pathological process. Rossiisky Fiziologichesky Zhurnal Imeni I.M. Sechenova. 2010; 96 (7): 696–707. PMID: 20973174. [In Russ.]
17. Skulachev V.P. Energy of biological membranes. Moscow: Nauka; 1989: 564. [In Russ.]
18. Shifrin A.G., Gorenshtein M.L. Recovery of biostability in sepsis. Zaporozhye: Ekspert; 2004: 300. [In Russ.]
19. Novak F., Heyland D.K., Avenell A., Drover J.W., Su X. Glutamine sup" plementation in serious illness: a systematic review of the evidence. Crit. Care Med. 2002; 30 (9): 2022–2029. http://dx.doi.org/10.1097/ 00003246"200209000"00011. PMID: 12352035
20. Peterson M.D., Rhea M.R., Alvar B.A. Maximizing strength development in athletes: a meta"analysis to determine the dose"response relationship. J. Strength Cond. Res. 2004; 18 (2): 377–382. http://dx.doi.org/ 10.1519/00124278"200405000"00031. PMID: 15142003
21. Tsvetkov D.S. Immunonutrition: new opportunities of treatment of metabolic disorders in critically ill patients. Effektivnaya Farmakoterapiya. 2014; 6: 28–35. [In Russ.]
22. Verizhnikova E.V., Doroninko L.M. Application of Mexidol in intensive care of patients with multiorgan failure. Byulleten Eksperimentalnoi Biologii i Meditsiny. 2006; приложение 1: 104–107. [In Russ.]
23. Voronina T.A. Mexidol: main neuropsychotropic effects and mecha" nisms of action. Farmateka. 2009; 6: 35–38. [In Russ.]
24. Zvyagin A.A., Rodionova S.S. Pharmaconutrients in parenteral nutri" tion of patients with sepsis (review). Vestnik Intensivnoi Terapii. 2011; 4: 23–29. [In Russ.]
Review
For citations:
Nazaretyan V.V., Lukach V.N., Kulikov A.V. The Effectiveness of Combined Use of Antioxidant and Glutamine in Abdominal Sepsis. General Reanimatology. 2017;13(2):52-60. https://doi.org/10.15360/1813-9779-2017-2-52-60
Views:
1157
Email this article 